Correlation Between Agios Pharm and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Mereo BioPharma Group, you can compare the effects of market volatilities on Agios Pharm and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Mereo BioPharma.
Diversification Opportunities for Agios Pharm and Mereo BioPharma
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Agios and Mereo is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Agios Pharm i.e., Agios Pharm and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Agios Pharm and Mereo BioPharma
Given the investment horizon of 90 days Agios Pharm is expected to generate 1.03 times more return on investment than Mereo BioPharma. However, Agios Pharm is 1.03 times more volatile than Mereo BioPharma Group. It trades about -0.04 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.08 per unit of risk. If you would invest 4,473 in Agios Pharm on November 2, 2024 and sell it today you would lose (1,019) from holding Agios Pharm or give up 22.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Mereo BioPharma Group
Performance |
| Timeline |
| Agios Pharm |
| Mereo BioPharma Group |
Agios Pharm and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Mereo BioPharma
The main advantage of trading using opposite Agios Pharm and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Agios Pharm vs. Surrozen | Agios Pharm vs. Armata Pharmaceuticals | Agios Pharm vs. Pasithea Therapeutics Corp | Agios Pharm vs. Aditxt Inc |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |